Gilead Sciences brings 4 presentations to BPI 2026 in Boston. Its sessions span cell line development, upstream scale-down and purification. One argues that gassing strategy is a critical lever for a predictive scale-down model, and another uses automated high-throughput screening to optimize polishing chromatography for challenging bispecific antibodies.
| Organization | BPI 2026 Attendance |
|---|---|
Gilead Sciences Foster City, California | 1 Principal Scientist · 1 Senior Associate Scientist · 1 Senior Scientist · 1 Associate Director, Cell Line Development |
Global biopharmaceutical company with marketed medicines in virology, oncology and inflammation. | Talk Wed Sep 23 9:30am–10:00am Talk Wed Sep 23 2:00pm–2:30pm Talk Thu Sep 24 5:00pm–5:30pm Talk Fri Sep 25 11:45am–12:15pm |
Instantly find 20 buyers from Gilead Sciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction